Status:
RECRUITING
Case Notes Review on Patients With Hereditary Haemorrhagic Telangiectasia
Lead Sponsor:
Imperial College London
Collaborating Sponsors:
The Margaret Hayton HHT Fund
Conditions:
Telangiectasia, Hereditary Hemorrhagic
Eligibility:
All Genders
Brief Summary
This observational study is for individuals with Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations that are reviewed at the Hammersmith Hospital, London.
Detailed Description
The Hammersmith Hospital provides a clinical service for patients with Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations that is unique in the United Kingdom. Measuremen...
Eligibility Criteria
Inclusion
- Patients attending Hammersmith Hospital
Exclusion
- None
Key Trial Info
Start Date :
January 1 2000
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2028
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT00230685
Start Date
January 1 2000
End Date
January 1 2028
Last Update
September 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Respiratory Medicine, Hammersmith Hospital
London, United Kingdom, W12 0NN